Search Results - "Ng, Theodore"

Effect of dietary Fatty acids on human lipoprotein metabolism: a comprehensive update by Ooi, Esther M M, Watts, Gerald F, Ng, Theodore W K, Barrett, P Hugh R

“…Dyslipidemia is a major risk factor for cardiovascular disease (CVD). Dietary fatty-acid composition regulates lipids and lipoprotein metabolism and may confer…”
Get full text

Dose-Dependent Effects of Rosuvastatin on the Plasma Sphingolipidome and Phospholipidome in the Metabolic Syndrome by Ng, Theodore W. K, Ooi, Esther M. M, Watts, Gerald F, Chan, Dick C, Weir, Jacquelyn M, Meikle, Peter J, Barrett, P. Hugh R

“…Context: Statins are effective cholesterol-lowering agents that reduce cardiovascular disease risk but also have pleiotropic effects that may extend to other…”
Get full text

Association of Plasma Ceramides and Sphingomyelin With VLDL apoB-100 Fractional Catabolic Rate Before and After Rosuvastatin Treatment by Ng, Theodore W. K, Ooi, Esther M. M, Watts, Gerald F, Chan, Dick C, Meikle, Peter J, Barrett, P. Hugh R

“…Introduction: The objective of the study was to examine post hoc associations between plasma sphingolipids and lipoprotein kinetics in men with the metabolic…”
Get full text

Metabolomics and ischaemic heart disease by Rasmiena, Aliki A, Ng, Theodore W, Meikle, Peter J

“…Ischaemic heart disease accounts for nearly half of the global cardiovascular disease burden. Aetiologies relating to heart disease are complex, but…”
Get more information

Effect of Weight Loss on LDL and HDL Kinetics in the Metabolic Syndrome: Associations with changes in plasma retinol-binding protein-4 and adiponectin levels by Ng, Theodore W.K, Watts, Gerald F, Barrett, P. Hugh R, Rye, Kerry-Anne, Chan, Dick C

“…OBJECTIVE:--The purpose of this study was to examine the effect of weight loss on LDL and HDL kinetics and plasma retinol-binding protein-4 (RBP-4) and…”
Get full text

Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease by Ooi, Esther M.M., Chan, Doris T., Watts, Gerald F., Chan, Dick C., Ng, Theodore W.K., Dogra, Gursharan K., Irish, Ashley B., Barrett, P. Hugh R.

“…Moderate chronic kidney disease (CKD) (defined by an estimated glomerular filtration rate of 30–60 ml/min) is associated with mild hypertriglyceridemia related…”
Get full text

Weight Loss and Exercise Alter the High-Density Lipoprotein Lipidome and Improve High-Density Lipoprotein Functionality in Metabolic Syndrome by Khan, Anmar A, Mundra, Piyushkumar A, Straznicky, Nora E, Nestel, Paul J, Wong, Gerard, Tan, Ricardo, Huynh, Kevin, Ng, Theodore W, Mellett, Natalie A, Weir, Jacquelyn M, Barlow, Christopher K, Alshehry, Zahir H, Lambert, Gavin W, Kingwell, Bronwyn A, Meikle, Peter J

“…OBJECTIVE—High-density lipoprotein (HDL) lipid composition and function may better reflect cardiovascular risk than HDL cholesterol concentration. This study…”
Get full text

Dietary fatty acids and lipoprotein metabolism: new insights and updates by Ooi, Esther M.M., Ng, Theodore W.K., Watts, Gerald F., Barrett, P. Hugh R.

“…Dyslipidemia is a powerful risk factor for cardiovascular disease (CVD). Dietary fatty acid composition regulates lipids and lipoprotein metabolism and may…”
Get full text

Apolipoprotein A-II: evaluating its significance in dyslipidaemia, insulin resistance, and atherosclerosis by Chan, Dick C, Ng, Theodore W K, Watts, Gerald F

“…Reduced HDL cholesterol, commonly found in subjects with obesity and type 2 diabetes, is associated with increased risk of cardiovascular disease (CVD)…”
Get more information

Low-Density Lipoprotein Receptor–Dependent and Low-Density Lipoprotein Receptor–Independent Mechanisms of Cyclosporin A–Induced Dyslipidemia by Kockx, Maaike, Glaros, Elias, Kan, Betty, Ng, Theodore W, Berbée, Jimmy F.P, Deswaerte, Virginie, Nawara, Diana, Quinn, Carmel, Rye, Kerry-Anne, Jessup, Wendy, Rensen, Patrick C.N, Meikle, Peter J, Kritharides, Leonard

“…OBJECTIVE—Cyclosporin A (CsA) is an immunosuppressant commonly used to prevent organ rejection but is associated with hyperlipidemia and an increased risk of…”
Get full text

Adiponectin and other Adipocytokines as Predictors of Markers of Triglyceride-Rich Lipoprotein Metabolism by Chan, Dick C, Watts, Gerald F, Ng, Theodore W.K, Uchida, Yoshiaki, Sakai, Naohiko, Yamashita, Shizuya, Barrett, P. Hugh R

“…Adipocytokines are bioactive peptides that may play an important role in the regulation of glucose and lipid metabolism. In this study, we investigated the…”
Get full text

High density lipoprotein efficiently accepts surface but not internal oxidised lipids from oxidised low density lipoprotein by Rasmiena, Aliki A., Barlow, Christopher K., Ng, Theodore W., Tull, Dedreia, Meikle, Peter J.

“…Oxidised low density lipoprotein (oxLDL) contributes to atherosclerosis, whereas high density lipoprotein (HDL) is known to be atheroprotective due, at least…”
Get full text

Effect of fenofibrate and atorvastatin on VLDL apoE metabolism in men with the metabolic syndrome by Ooi, Esther M.M., Ng, Theodore W.K., Watts, Gerald F., Chan, Dick C., Barrett, P. Hugh R.

“…We examined the effects of fenofibrate and atorvastatin on very low density lipoprotein (VLDL) apolipoprotein (apo)E metabolism in the metabolic syndrome…”
Get full text

Omega-3 fatty acid ethyl ester supplementation decreases very-low-density lipoprotein triacylglycerol secretion in obese men by Wong, Annette T Y, Chan, Dick C, Ooi, Esther M M, Ng, Theodore W K, Watts, Gerald F, Barrett, P Hugh R

“…Dysregulated VLDL-TAG (very-low-density lipoprotein triacylglycerol) metabolism in obesity may account for hypertriacylglycerolaemia and increased…”
Get more information

Adipocytokines and VLDL metabolism : Independent regulatory effects of adiponectin, insulin resistance, and fat compartments on VLDL apolipoprotein B-100 kinetics? by NG, Theodore W. K, WATTS, Gerald F, FARVID, Maryam S, CHAN, Dick C, BARRETT, P. Hugh R

“…We investigated the relationship of plasma adipocytokine concentrations with VLDL apolipoprotein B (apoB)-100 kinetics in men. Plasma adiponectin, leptin,…”
Get full text

Plasma markers of cholesterol homeostasis in metabolic syndrome subjects with or without type-2 diabetes by Ooi, Esther M.M, Ng, Theodore W.K, Chan, Dick C, Watts, Gerald F

“…Abstract Aims We investigated the associations between indices of cholesterol metabolism and features of the metabolic syndrome (MS) in the presence and…”
Get full text

Synthetic hydroxyapatite and its use in bioactive coatings by Guillen-Romero, Luis Daniel, Oropeza-Guzmán, Mercedes Teresita, López-Maldonado, Eduardo Alberto, Iglesias, Ana Leticia, Paz-González, Juan Antonio, Ng, Theodore, Serena-Gómez, Eduardo, Villarreal-Gómez, Luis Jesús

“…An approach to solve the limitations of autologous bone grafting procedures in bone injury treatment is to develop bioactive coatings in the implantation…”
Get full text

Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome by Ng, Theodore W K, Chan, Dick C, Barrett, P Hugh R, Watts, Gerald F

“…Reduced HDL (high-density lipoprotein) concentration in the MetS (metabolic syndrome) is associated with increased risk of cardiovascular disease and is…”
Get more information

Genetic determinants of apolipoprotein B-100 kinetics by Ng, Theodore W K, Ooi, Esther M M, Watts, Gerald F, Chan, Dick C, Barrett, P Hugh R

“…We review stable isotope tracer studies of apolipoprotein B-100 (apoB) kinetics concerning genetic polymorphisms and mutations that affect human lipoprotein…”
Get full text

Temperature effect on the porosity of hydroxyapatite scaffolds and its use in tissue engineering by Zarate-Córdova, Vareska Lucero, Oropeza-Guzmán, Mercedes Teresita, López-Maldonado, Eduardo Alberto, Iglesias, Ana Leticia, Ng, Theodore, Serena-Gómez, Eduardo, Pérez-González, Graciela Lizeth, Villarreal-Gómez, Luis Jesús

“…The search for a suitable bone replacement is of great importance due to the difficulty to use autologous transplants. Hence, the objective of this work is to…”
Get full text